marcellomycin has been researched along with daunorubicin in 6 studies
| Studies (marcellomycin) | Trials (marcellomycin) | Recent Studies (post-2010) (marcellomycin) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | marcellomycin (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahle, M; Marquardt, H; Radenz, G; Schaefer, A; Steinheider, G | 1 |
| Bachur, NR; Bernstein, AL; Dodion, P; Fox, BM | 1 |
| Ogawa, M | 1 |
| Crooke, ST; DuVernay, VH; Mong, S; Strong, JE | 1 |
| Brown, BJ; Marsh, JC; Nierenburg, MM | 1 |
| Crooke, ST; Loth, H; Seeber, S | 1 |
1 review(s) available for marcellomycin and daunorubicin
| Article | Year |
|---|---|
[Current status of clinical results of new antitumor drugs].
Topics: Aminoacridines; Amsacrine; Anthracyclines; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Carboplatin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Eflornithine; Epirubicin; Humans; Idarubicin; Mitoxantrone; Naphthacenes; Neoplasms; Organoplatinum Compounds; Ornithine; Ribavirin | 1985 |
5 other study(ies) available for marcellomycin and daunorubicin
| Article | Year |
|---|---|
Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Friend murine leukemia virus; Glycoproteins; Hemoglobins; Leukemia, Erythroblastic, Acute; Mannose; Mice; Tunicamycin | 1991 |
Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.
Topics: Anaerobiosis; Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Kinetics; Liver; Male; Mitoxantrone; NAD; NADP; Naphthacenes; Rats; Rats, Inbred Strains; Xanthine Oxidase | 1987 |
Interaction of anthracyclines with covalently closed circular DNA.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Bleomycin; Carubicin; Centrifugation, Density Gradient; Daunorubicin; Diffusion; DNA, Circular; Doxorubicin; Drug Interactions; Electrophoresis, Agar Gel; Molecular Conformation; Naphthacenes | 1980 |
Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Dogs; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Male; Mice; Naphthacenes; Species Specificity | 1983 |
Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carubicin; Cell Nucleus; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Female; In Vitro Techniques; Mice; Naphthacenes | 1980 |